SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Samuel Johnson

PatientSamuel Johnson
Date of birth1970-09-18
IdentifiersMRN HR-EN008-SYN; SSN (made up) 000-08-7139
Document date2026-04-06
AuthorCatriona Bell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for new patient visit for severe recurrent depression and lifelong tics: depression work-up, sertraline and psychotherapy, safety assessment, and a request for neurology consultation. [S]

Objective

Hemoglobin: 14.6 g/dL; Sodium: 140 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 0.98 mg/dL; eGFR: 91 mL/min/1.73 m²; Glucose: 94 mg/dL; TSH: 2.1 mIU/L; Vitamin B12: 412 pg/mL; ALT: 24 U/L; PHQ-9: 21; GAD-7: 12; MDQ: 3; AUDIT-C: 0. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-04-06Body height183cmS
2026-04-06Body weight98kgS
2026-04-06Body mass index (BMI) [Ratio]29.3kg/m2S
2026-04-06Systolic blood pressure128mm[Hg]S
2026-04-06Diastolic blood pressure80mm[Hg]S
2026-04-06Heart rate84/minS
2026-04-06Respiratory rate16/minS
2026-04-06Body temperature36.7CelS
2026-04-06Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-06Hemoglobin [Mass/volume] in Blood14.6g/dL13.2-17.1 g/dLNormalS
2026-04-06Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-04-06Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-04-06Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
2026-04-06Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M91mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-06Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-04-06Thyrotropin [Units/volume] in Serum or Plasma2.1m[IU]/L0.45-4.5 mIU/LNormalS
2026-04-06Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma412pg/mL232-1245 pg/mLNormalS
2026-04-06Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-56 U/LNormalS
2026-04-06Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]21{score}S
2026-04-06Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]12{score}S
2026-04-06Total score [MDQ]3{score}S
2026-04-06Total score [AUDIT-C]0{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once daily in the morningOral route2026-04-06 to 2026-05-18completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Major depressive disorder, recurrent, severe, without psychotic features: low mood, loss of interest, poor sleep, guilt, and withdrawal from company for about three months on a background of depression that never fully lifted after a severe episode last year; first episode at about twenty; synthetic modern episode linked to his documented melancholyactiveconfirmed F33.2S — Synthetic modern diagnosis by DSM-5 criteria; the record makes no claim about his real mental health.
Motor and vocal tics since childhood, with ritual counting and stepping behaviors, never formally diagnosed; neurology evaluation requestedactiveconfirmed F95.9S — Synthetic presenting concern anchored to the documented tics; superseded by the diagnosis at the neurology consultation.
Blindness of the left eye since early childhood after scrofula (tuberculous cervical lymphadenitis), with old scars of the neck and face; right eye myopic, corrected to normal; synthetic modern coding linked to his documented loss of sight in one eyeactiveconfirmed H54.42S — Synthetic modern coding; the source does not say which eye, so the left is a synthetic choice.

Assessment

Plan of Treatment